Skip to content

Armada A1030-060Recalls & reported problems

Abbott Vascular Inc. · Armada 14 PTA Catheter 3.0 mm x 60 mm x 90 cm / Over-The-Wire · Class 2

All models of Armada (213)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08717648155802), received between Oct 10, 2022 and Jun 28, 2024 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Difficult to Advance” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 1 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Difficult to Advance1
  • Difficult to Remove1
  • Material Split, Cut or Torn1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJun 28, 2024Material Split, Cut or Torn; Material Split, Cut or Torn

    IT WAS REPORTED THAT DURING PREPARATION OF THE 3.0X60MM ARMADA 14 BALLOON DILATATION CATHETER, IT WAS NOTED THE BALLOON WAS PERFORATED. ANOTHER ARMADA BALLOON CATHETER WAS USED TO COMPLETE THE PROCEDURE. THERE WAS NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE AND NO PATIENT INVOLVEMENT. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19631851 ↗
  • MalfunctionOct 10, 2022Difficult to Remove; Difficult to Advance; Difficult to Remove; Difficult to Advance

    IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A HEAVILY CALCIFIED TIBIAL ARTERY THAT IS 90% STENOSED. THE 014 HT COMMAND GUIDE WIRE CROSSED LESION SUCCESSFULLY. THE 3.0X60MM ARMADA 14 BALLOON DILATATION CATHETER WAS ADVANCED AND USED TO PRE-DILATE THE LESION SUCCESSFULLY EVEN THOUGH RESISTANCE WAS MET DURING ADVANCEMENT WITH THE GUIDE WIRE. ONCE REMOVED THE 4.0X38MM XIENCE PRIME STENT DELIVERY SYSTEM WAS ATTEMPTED TO ADVANCE OVER THE WIRE; HOWEVER, RESISTANCE WAS MET WITH THE GUIDE WIRE. THE SAME ARMADA 14 BALLOON WAS ATTEMPTED TO BE ADVANCED OVER THE GUIDE WIRE, BUT MET RESISTANCE WAS NOTED AGAIN. THE BALLOON AND GUIDE WIRE WERE REMOVED TOGETHER. THE GUIDE WIRE WAS REMOVED AND THE COATING WAS NOTED TO BE PEELED BUT REMAINING ON THE GUIDE WIRE. ANOTHER COMMAND GUIDE WIRE AND XIENCE PRIME WERE USED TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WERE NO CLINICALLY SIGNIFICANT DELAY REPORTED. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15571248 ↗

Other Catheter, angioplasty, peripheral, transluminal devices

All Catheter, angioplasty, peripheral, transluminal devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page